Pathstone Family Office, LLC Arvinas, Inc. Transaction History

Pathstone Family Office, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Oct 23, 2023	BUY	$32.47 - $57.24 $40,295 - $71,034	1,241 New	1,241 $42,000
Q4 2022 Feb 13, 2023	BUY	$32.47 - $57.24 $40,295 - $71,034	1,241 New	1,241 $42,000
Q1 2021 May 14, 2021	SELL	$58.19 - $91.37 $58,190 - $91,370	-1,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$29.88 - $56.74 $29,880 - $56,740	-1,000 Closed	0 $0
Q1 2020 Jun 11, 2020	BUY	$33.0 - $54.5 $33,000 - $54,500	1,000 New	1,000 $40,000
Q1 2020 May 07, 2020	SELL	$33.0 - $54.5 $33,000 - $54,500	-1,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$15.39 - $44.38 $15,390 - $44,380	1,000 New	1,000 $411,000

229

68.4M

226K

285K

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $997M
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

Stay updated on Pathstone Family Office, LLC with notifications on news.